Shahram Jacobs
Sherman Oaks Hospital(US)Probity Medical Research(CA)
Research Areas
Psoriasis: Treatment and Pathogenesis, Diabetes Treatment and Management, Estrogen and related hormone effects, Dermatology and Skin Diseases, Pancreatic function and diabetes
Most-Cited Works
- → Safety and efficacy of envudeucitinib, a highly selective, oral allosteric TYK2 inhibitor, in patients with moderate-to-severe plaque psoriasis: Results from the 52-week open-label extension period of the phase 2 STRIDE study(2025)2 cited
- → Deucravacitinib in Plaque Psoriasis: Immune Response to and Safety of Pneumococcus and Tetanus Toxoid Vaccines in the POETYK LTE Trial(2025)